REMPATH HEALTH LTD
REMPATH HEALTH LTD
Contact & Details
Contact
Registered Address
3 Derek Ashton Court 77 Mottram Road Stalybridge SK15 2QP England
Full company profile for REMPATH HEALTH LTD (16381258), an active company based in Stalybridge, England. Incorporated 11 Apr 2025. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Financial History
Revenue, profit, EBITDA and key financial figures
No Financial Data Available
Financial information will appear here once available.
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Emmett Reidy | Director | Irish | England | 11 Apr 2025 | Active |
| Morgan Reidy | Director | Irish | England | 11 Apr 2025 | Active |
| Ross Huntley | Director | British | England | 11 Apr 2025 | Active |
Persons with Significant Control
Persons with Significant Control (2)
Familia Investments Ltd
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Meaha Ltd
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 24 Oct 2025 | Officers | Termination of Ross Huntley as director on 6 Oct 2025 | |
| 11 Apr 2025 | Incorporation | Company incorporated |
Termination of Ross Huntley as director on 6 Oct 2025
Company incorporated
Recent Activity
Latest Activity
Termination of Ross Huntley as director on 6 Oct 2025
7 months ago on 24 Oct 2025
Company incorporated
1 years ago on 11 Apr 2025
